Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression

Cancer

Volumn 92, Issue 6, 2001, Pages 1556-1566

  Zhan, Maocheng ^a   Yu, Dihua ^a   Lang, Aiqing ^a   Li, Lan ^a   Pollock, Raphael E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Doxorubicin; Multidrug resistance; P53; Soft tissue sarcoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA FRAGMENT; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; COLONY FORMATION; CYTOTOXICITY; DRUG EFFICACY; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SOFT TISSUE SARCOMA;

EID: 0035883628     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010915)92:6<1556::AID-CNCR1482>3.0.CO;2-S     Document Type: Article

References (27)

1. Combined modality treatment of extremity of soft tissue sarcomas
2. Sarcomas of soft tissues
3. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas
4. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas
5. Soft tissue sarcoma metastasis from colon expansion of p53 mutated tumor cells
6. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas
7. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents
8. P53 status and the efficacy of cancer therapy in vivo
9. Expression of p53 and glutathione S-transferase-π relates to clinical drug resistance in non-small cell lung cancer
10. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
11. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: A gene therapy approach for drug-resistant cancers
12. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells
13. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advancer head and neck cancers
14. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
15. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control
16. In vitro characterisation of soft tissue tumor chemosensitivity
17. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis
18. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
19. Expression of p-glycoprotein in high-grade osteosarcoma in relation to clinical outcome
20. Relationship between p-glycoprotein expression and p53 status in high-grade osteosarcoma
21. P-glycoprotein expression: Critical determinant in the response to osteosarcoma chemotherapy
22. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
23. The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53
24. Multidrug resistance: Clinical relevance in solid tumors and strategies for circumvention
25. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
26. A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC833 in combination with doxorubicin in patient with solid tumors
27. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas